Skip to content

Brief Behavioral Activation Treatment for Depression With Inpatients

An Evaluation of Brief Behavioral Activation Treatment for Depression With Moderate to Severely Depressed Inpatients - A Small Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02712918
Enrollment
23
Registered
2016-03-18
Start date
2014-01-31
Completion date
2014-10-31
Last updated
2016-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Depression, Inpatient, Acute, Brief Behavioral Activation Treatment for Depression

Brief summary

The purpose of the current study was to examine Brief Behavioral Activation Treatment for Depressions (BATD) effectiveness, credibility, and acceptability with moderate to severly depressed inpatients. The study is a systematic replication of a randomized controlled trail from 2003, that provided initial support for BATD With inpatients. The current study compared BATD to Treatment as Usual in a randomized controlled trial.

Interventions

Behavioral treatment of depression which focuses on increasing the Level of positive reinforcement through systematic and goal directed activation of behavior. Goal and values are assessed and used to determine target behaviors.

OTHERStandard Care

Treatment as usual at the ward

Sponsors

Oslo Metropolitan University
CollaboratorOTHER
Lovisenberg Diakonale Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Moderate to severe depression (BDI-II \> 28 Points). * Admission length of at least 3 days * Evaluated to benefit from depression treatment by unit psychiatrist.

Exclusion criteria

* Current psychotic disorder * Previously diagnosis with psychotic disorder (including Bipolar disorder)

Design outcomes

Primary

MeasureTime frame
Change of Beck's Depression Inventory-II from baselineChange from baseline (second day of admission) to discharge from the ward (maximum 21 days, expected average of 10 days).

Secondary

MeasureTime frameDescription
Treatment Evaluation Inventory - Short FormPrior to discharge from the ward (maximum 21 days, expected average of 10 days)..Only BATD group
Credibility and Expectancies QuestionnaireSecond day of admission. After first sessions of BATD.Only BATD group

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026